BioCardia, Inc. financial data

Symbol
BCDA, BCDAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
320 Soquel Way, Sunnyvale, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Tiger X Medical, Inc. (to 10/17/2016), Cardo Medical, Inc. (to 5/25/2011), CLICKNSETTLE COM INC (to 10/20/2008), NAM CORP (to 3/29/2000)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 64.9 % -68.5%
Debt-to-equity -644 % -675%
Return On Equity 1.42 K %
Return On Assets -262 % -102%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.7 M shares +32.5%
Common Stock, Shares, Outstanding 26.8 M shares +32.8%
Entity Public Float 48 M USD +142%
Common Stock, Value, Issued 27 K USD +35%
Weighted Average Number of Shares Outstanding, Basic 25.1 M shares +24.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.58 M USD -27.1%
Costs and Expenses 10.9 M USD -19.1%
Operating Income (Loss) -10.4 M USD +13.9%
Nonoperating Income (Expense) 72 K USD +7100%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.3 M USD +14.5%
Earnings Per Share, Basic -0.47 USD/shares +27.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 949 K USD -80.5%
Accounts Receivable, after Allowance for Credit Loss, Current 58 K USD -62.1%
Assets, Current 1.26 M USD -76.2%
Property, Plant and Equipment, Net 75 K USD -52.5%
Operating Lease, Right-of-Use Asset 1.17 M USD -22.2%
Other Assets, Noncurrent 171 K USD -0.58%
Assets 2.68 M USD -62.4%
Accounts Payable, Current 1.03 M USD +19.6%
Accrued Liabilities, Current 116 K USD +205%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 4.07 M USD +1.78%
Operating Lease, Liability, Noncurrent 883 K USD -28.1%
Liabilities 4.95 M USD -5.24%
Retained Earnings (Accumulated Deficit) -154 M USD -7.17%
Stockholders' Equity Attributable to Parent -2.28 M USD -220%
Liabilities and Equity 2.68 M USD -62.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.53 M USD +40.2%
Net Cash Provided by (Used in) Financing Activities 1.38 M USD +2050%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 26.8 M shares +32.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -154 K USD +93.9%
Deferred Tax Assets, Valuation Allowance 36.7 M USD +8.03%
Deferred Tax Assets, Gross 36.7 M USD +8.03%
Operating Lease, Liability 1.23 M USD -21%
Depreciation 81 K USD -7.96%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.42 M USD -14.2%
Property, Plant and Equipment, Gross 788 K USD -1.38%
Operating Lease, Liability, Current 345 K USD +5.51%
Lessee, Operating Lease, Liability, to be Paid, Year Two 514 K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 499 K USD +2.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure -99%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 193 K USD +91.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44 K USD -91.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25 M shares 0%
Unrecognized Tax Benefits 1.68 M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44 K USD -91.4%
Operating Lease, Payments 318 K USD +23.3%
Additional Paid in Capital 152 M USD +4.22%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 19 K USD -13.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 956 K USD -16.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%